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Introduction: Over the past decade the United States (US) has seen a decrease in
advanced cancer diagnoses. There has also been an increase in the number of cancer
survivors returning to work. Cancer screening behaviors among survivors may play an
important role in their return-to-work process. Adherence to a post-treatment cancer
screening protocol increases early detection of secondary tumors and reduces potentially
limiting side-effects. We compared screening trends among all cancer survivors, working
survivors, and the general population over the last decade.Materials andMethods:Trends
in adherence to recommended screening were analyzed by site-specific cancer. We used
the Healthy People goals as a measure of desired adherence.We selected participants 18+
years from 1997 to 2010 National Health Interview Survey for years where detailed cancer
screening information was available. Using the recommendations of the American Cancer
Society as a guide, we assessed adherence to cancer screening across the decade.There
were 174,393 participants. Analyses included 7,528 working cancer survivors representing
3.8 million US workers, and 119,374 adults representing more than 100 million working
Americans with no cancer history. Results: The US population met the Healthy People
2010 goal for colorectal screening, but declined in all other recommended cancer screen-
ing. Cancer survivors met and maintained the HP2010 goal for all, except cervical cancer
screening. Survivors had higher screening rates than the general population. Among sur-
vivors, white-collar and service occupations had higher screening rates than blue-collar
survivors. Conclusion: Cancer survivors report higher screening rates than the general
population. Nevertheless, national screening rates are lower than desired, and disparities
exist by cancer history and occupation. Understanding existing disparities, and the impact
of cancer screening on survivors is crucial as the number of working survivors increases.
Keywords: cancer, screening, survivors, occupation, mammogram, papanicolaou test, colorectal screening
INTRODUCTION
There is an increasing global cancer burden associated with aging
and the world’s population growth, claiming more than 570,000
lives in 2011 in the United States (US) alone. Yet in the past decade
the US has seen a significant decline in the diagnoses of advanced
stages of the most common cancers (Jemal et al., 2010a). This
decrease may in part be attributed to improvements in health
behaviors, such smoking, diet, and/or adherence to recommended
screening (Jemal et al., 2011). Screening is one of the most impor-
tant cancer preventive behaviors (Matejic et al., 2011), as such
regular screening is likely to have contributed significantly to the
reduction of late diagnoses.
Earlier diagnoses and improved treatments have resulted in
a growing number of cancer survivors (Jemal et al., 2010b;
Lansdorp-Vogelaar et al., 2012) who enjoy better prognoses and
a better quality of life. Consequently, survivors are staying or
returning to work in greater numbers than before which has
two interrelated beneficial consequences. First, survivors, who are
more likely to engage in cancer preventive behavior than those with
no cancer history (Hudson et al., 2009; Roach et al., 2009), benefit
from continued access to employer subsidized health insurance to
cover screening costs and, secondly, their experiences and screen-
ing behaviors are expected to influence attitudes toward screening
within the workplace (Messner and Vera, 2011).
We expect cancer survivors to report higher screening adher-
ence than the general population due to their first-hand knowledge
of the benefits of early detection of recurrences and second pri-
mary tumors. In fact, 10% of all new cancers are diagnosed
in cancer survivors, and these second primaries are the sixth
leading cause of cancer deaths (Mayer et al., 2007). However,
because employment-based health insurance varies by occupation
(Bradley et al., 2002), one may expect differences in adherence
to screening, and consequently cancer survivorship by occupation
and employment status (Kennedy et al., 2007; National Cancer
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Institute (NCI), 2007). Our previous work showed health-related
disparities by cancer history within working survivors, as well as
disparities by occupation (Clarke et al., 2011). Thus, we aim to
identify any differences in prevention behaviors by cancer history
and occupation. We assessed the adherence to recommended col-
orectal, breast, cervical, and prostate cancer screening among the
general population compared to all cancer survivors and compared
to the subpopulation of working survivors.
The specific aim of this study is to evaluate the degree to which
the population in general and cancer survivors in particular met
recommended screening goals. The collective goals for national
screening rates have been set by the US Department of Health and
Human Services (USDHHS). These benchmarks are put forward
as the “Healthy People objectives” and serve to guide individuals
toward making informed health decisions, as well as measure the
impact of health-related prevention activities. We used Healthy
People 2010 (HP2010) objectives as the benchmark for evaluating
whether our populations of interest met cancer screening goals
between 1999 and 2010. Throughout this study the term cancer
survivor is used to identify persons who have had a cancer diagno-
sis, are living with the disease, as well as persons who no longer have
the disease (National Coalition for Cancer Survivorship (NCCS),
1986).
MATERIALS AND METHODS
STUDY POPULATION
The study population was selected from adult participants
(≥18 years) of the National Health Interview Survey (NHIS).
The NHIS collects demographic and health information from
a representative sample of the non-institutionalized US civilian
population annually. Information is collected by household; one
adult per family is randomly selected and administered questions
related to health, including questions about cancer history and
cancer-related health behaviors such as cancer screening.
The study population was divided by cancer status; cancer sur-
vivors were then compared to the general population (i.e., persons
with and without cancer). We included cancer survivors in the
general population because the goals set and screening adher-
ence reported by Healthy People are reflective of all persons
regardless of their cancer history. Participants responding “Yes”
to “Have you EVER been told by a doctor or other health pro-
fessional that you had. . .Cancer or a malignancy of any kind?”
were defined as cancer survivors (n= 12,990) throughout this
study. We included all NHIS records between 1997 and 2010
which provided detailed information on screening behavior. Using
the recommendations from the American Cancer Society (ACS)
as a guide, we identified individuals ≥18 years who adhered to
the recommended screening guidelines for cancers amenable to
screening between 1997 and 2010, where data were available
(n= 174,393).
EMPLOYMENT STATUS AND OCCUPATION
Employment status was determined by whether or not respon-
dents were working during the week prior to the NHIS interview.
Employed participants were stratified by occupational sector. For
occupational sector, we used a four-category variable commonly
used by the National Center for Health Statistics, which was based
on the 2000 US Census and included the categories of white-collar
workers (e.g., banker), service workers (e.g., police officer), farm
(including fishing and forestry) workers, and blue-collar work-
ers (e.g., construction worker) (Krieger et al., 2005; Sorerholm,
2006).
MEASURING ADHERENCE TO SCREENING RECOMMENDATIONS
The US Preventive Services Task Force (USPSTF) provides cancer
screening recommendations based on comprehensive and system-
atic reviews of clinical evidence. However the American populace
is more familiar with the ACS and the National Cancer Institute
(NCI) and their web pages which offer screening information to
the public. Thus, the information disseminated by these agencies is
likely to influence the screening behaviors of those acting indepen-
dent of physician recommendations and will reinforce population
screening behavior toward meeting the HP2010 goals. In this study
we use ACS guidelines to assess the adherence to recommended
screening in the US population (Table 1). These guidelines dif-
fer slightly from USPSTF, in that ACS recommends an age for
first screening mammography 10 years younger than the USPSTF
(Smith et al., 2012).
Survey participants were asked information regarding relevant
screening tests according to their age and gender, regardless of their
cancer history. Where appropriate, analyses incorporated changes
to recommendations during the course of the study period. For
example, historic recommendations for Papanicolaou (Pap) tests
were “testing should be initiated among women 18 years of age
or among those who are sexually active (whichever is first) once
every 2 years if the conventional cervical cells smear was used and
every 3 years if the newer liquid-based test was used.” However,
in 2009 in accordance with the USPSTF, the ACS changed the
recommended age at initial screening to 21 years among women
regardless of prior sexual activity, while maintaining the same
screening interval. Despite Prostate Specific Antigen (PSA) testing
not being endorsed as a general screening test by the USPSTF, we
included it in our analyses since prostate cancer is the most com-
monly diagnosed non-skin cancer and the second leading cause
of cancer deaths (after lung cancer) in US men (American Cancer
Society (ACS), 2012). We also note that prostate cancer has the
highest prevalence rate among US males after non-melanoma skin
cancer (Gilligan, 2009).
We measured adherence to screening among the general pop-
ulation and compared them to cancer survivors and working
survivors. Using the four occupational sectors (white-collar, blue-
collar, farm, and service) we also made comparisons across
occupations.
Adherence (outcome of interest) was measured as abiding by
any of the recommended guidelines within the specified time
frame for gender-specific age groups (Table 1). Persons within
the qualifying age and gender categories but whose screening
fell outside of the recommended timeframe or who reported
not being screened were recorded as non-adherent. In addition
to Pap tests and PSA screenings we evaluated adherence to col-
orectal screening (sigmoidoscopy, colonoscopy, proctoscopy, and
home or office stool blood) for men and women, mammogram
for women 40 years or older, and manual breast examination for
women 20 years or older.
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Table 1 | Recommendations for Cancer screening as suggested by the American Cancer Society.
Screening exam Recommendations (1999–2010)
Breast cancer
screening
Mammography (an digital or
film x ray picture of the breast)
Women ≥40 years should have mammograms every 1–2 years
Women with a higher than average risk of breast cancer should discuss
frequency of, and age at first screening with their health care providers
Clinical breast exam Every 3 years for women in their 20s and 30s and every year for women
≥40 years
Cervical cancer
screening
Pap test* 1999 Sexually active women or those ≥18 years, annual Pap test and pelvic
examination. After more than 3 consecutive satisfactory normal annual
examinations, the Pap test may be performed less frequently at the
discretion of the physician
2002 At least 3 years after first vaginal intercourse, but no later than 21 years
old, women should have regular Pap tests every 1 year or every 2 years
with newer liquid-based test. Women ≥30 with 3 consecutive normal
Pap test results may get screened every 2–3 years
Women >30 years may also get screened every 3 years with either the
conventional or liquid-based Pap test, in addition to the human
papillomavirus (HPV) test
Women ≥70 years with 3 or more consecutive normal Pap tests and no
abnormal Pap test results in the last 10 years may discontinue testing
Women who have had a total hysterectomy for non-cancer related
reasons may discontinue testing
2009 Screening should begin at age 21
Women 21–29 years should have Pap test every 3 years. If Pap test
result is abnormal then women should have a HPV test
Women 30–65 years should have both a Pap test and an HPV test every
5 years. It is also okay to have a Pap test alone every 3 years
Women >65 years who have had regular screenings with normal results
should not be screened for cervical cancer
However those who have been diagnosed with cervical pre-cancer
should continue to be screened
Colorectal
screening
Men and women ≥50 years
Flexible sigmoidoscopy Every 5 years
†
, or
Colonoscopy Every 10 years, or
CT colonography (virtual colonoscopy) Every 5 years
†
Double-contrast barium enema Every 5 years
†
Fecal occult blood test (gFOBT) Annually
‡
, or
Fecal immunochemical test (iFOBT/FIT) Annually
‡
, or
Stool DNA test (sDNA) Interval uncertain (possibly 3–5 years)
‡
Prostate cancer
screening
Prostate specific antigen (PSA) blood
test/velocity test
[How PSA measures rise over time]
Discuss with physician the pros and cons of receiving a baseline PSA
and follow-up test if necessary
PSA density test [Ratio of PSA level
to size of prostate gland]
Men at higher than normal risk (Blacks, men whose father, brother or
son have been diagnosed with prostate cancer) discuss screening with
physician at 45 years
Percent-free PSA [Ratio of unattached PSA
in blood to total PSA]
Men ≥50 years discuss the harms and benefits of PSA screening with
physician
Age-specific PSA range Men with a previous PSA of ≥4 ng/ml in the blood, should be retested if
discussion with physician dictates a necessity
Digital rectal exam As recommended by physician
*In 2009 the recommendation for cervical cancer screening changed to pap tests every three years beginning at age 21. Recommendations now include HPV testing
every 5 years among women 30–65 years. HPV testing was not included in our analyses. † If test is positive, a colonoscopy should be done. ‡ A single test done in the
doctor’s office is not adequate for testing. A colonoscopy should be done if the test is positive.
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HEALTHY PEOPLE 2010
The HP2010 objectives were set to achieve a 10% improvement in
particular health characteristics and screening behaviors within
a 10-year period. The baseline was January 2000 figures (the
first year of the decade) based on data gathered from the NCHS
and other health statistics agencies. The health statistics obtained
for the January 2000 benchmarks were obtained from summary
measures recorded in 1999.
As Table 1 illustrates, colorectal screening encompasses a vari-
ety of screening methods at different intervals. Using the rec-
ommendations of the ACS, we examined fecal occult blood test
(FOBT), colonoscopy, and sigmoidoscopy jointly. The HP2010
goal was to increase to 50% the proportion of adults aged 50 and
older who had had a FOBT within the previous 2 years as well as
the proportion of persons in the same age group who had ever
had a sigmoidoscopy. There were no separate HP2010 goals for
colonoscopy.
Regarding breast cancer screening, the HP2010 goal was to
increase to 70% the proportion of women aged 40 and older who
had received a mammogram within the previous 2 years. No sep-
arate goals were set to address clinical breast exams for 2010. For
cervical cancer screening, the goal was to increase to 90% the pro-
portion of women aged 18 and older who had received a Pap test
within the previous 3 years (US Department of Health and Human
Services (HHS), 2000). Finally, there was no HP2010 target for
PSA screening as it is not recommended by any of the govern-
ing bodies. The majority of HP2010 goals are consistent with the
recommendations used to guide analyses in this study.
NHIS DATA
National Health Interview Survey questionnaires did not field
all cancer screening questions each year; however, to study
changes in preventive cancer screening we analyzed NHIS cancer
screening data whenever available within the decade. Data
were available for 2000, 2003, 2005, 2008, and 2010. Ques-
tions on cancer screening are located in the adult files of
2000, 2003, and 2008 and the periodic cancer module in 2005
and 2010. We used one common method of variable response
coding for all data years when the questions of interest were
available. For more information about the methods used for
cancer screening recodes, see ftp://ftp.cdc.gov/pub/Health_ Statis-
tics/NCHS/Program_Code/NHIS/2005/CANCRECO.sas accessed
March 12,2010 and ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS
/Program_Code/NHIS/2008/cancreco.sas accessed March 12,
2010. The NCHS uses three different formats for recording infor-
mation related to reported cancer screening behavior in order to
maximize the precision of information obtained as well as the
completeness of the data files (Breen et al., 2011). Fundamental
differences in formats included the various time codes.
The general questioning across the years included in these
analyses was as follows:“When did you have your MOST RECENT
(screening exam)?” We examined each format and used comple-
mentary but mutually exclusive categories to report adherence
to screening guidelines for each year. Participants responses to
“date,”“number of time units,”and“time interval”since last screen-
ing were re-coded using methods similar to (Breen et al., 2011).
The appropriate time interval was chosen for each cancer specific
screening according to ACS guidelines. In coding the occupational
sectors, The NHIS records information by job type, and indus-
try which can then be classified into the four broad occupational
sectors used in this study. The crosswalk for occupation was deter-
mined by the notes presented in the Appendix of the adult file and
guided by previous studies (Krieger et al., 2005; Sorerholm, 2006).
ANALYSES
We used methods developed to analyze population-based complex
survey data to compute the prevalence of adherence to recom-
mended cancer screening for the general population, as well as for
working and non-working cancer survivors over the past decade.
For the five screening tests of interest (mammography, clinical
breast exam, Pap test, colorectal, and PSA), dichotomous variables
were constructed to indicate whether the respondent reported
having the test within the recommended time period. The preva-
lence of cancer specific screening was computed by cancer status,
and then by occupational subgroup within the working cancer
survivors separately for each year. The SAS survey frequency pro-
cedure (SURVEYFREQ) was used to apply the appropriate weights
and adjustments for the complex sampling design of the NHIS
(SAS Institute Inc, 2003). The line graphs in Figures 1A–C display
the resulting screening rates.
To assess for cancer screening trends among working cancer
survivors, we used SAS general linear model procedure (GLM)
to perform a weighted linear regression of the annual design-
adjusted rates for each screening behavior on occupational group
and survey year nested in occupational group. This model pro-
vides simultaneous estimation of slopes and intercepts for each
occupational group. The weight used for each annual rate was
the inverse of its design-adjusted variance. We used contrasts to
compare the slopes of the regression lines representing each occu-
pation group. We present the estimate of the slope of the regression
line, the standard error, and significance level of the slope. We also
present comparisons among the slopes of the occupational groups
by cancer survivor status. Statistical significance was established at
the 0.05 probability level. SAS 9.3 (SAS Institute, Inc., Cary, NC)
was used for all analyses.
To create total estimates of US workers (including the sub-
populations); we applied the annual sample–person weights
and summed them over each annual group and the associated
subgroups.
RESULTS
TRENDS AMONG THE GENERAL POPULATION
Colorectal cancer screening
Within the general population (cancer survivors included), col-
orectal screening rates increased by a significant 16.6% repre-
senting more than 2.3 million Americans over the past decade
(Figure 1A). The most significant change was a 5.7% increase
between 2000 and 2003; however, there was an average annual
4.2% change. In 2010 the population met the HP2010 goal of 50%
of persons over age 50 years having a colorectal examination with
a prevalence of 54.6± 1.2% (Table 2).
Breast cancer screening
Rates for mammography showed little change between 1999 and
2010, with an average reported adherence of 69.7%. The US
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FIGURE 1 |Trend in adherence to screening among (A) the general US population (n=174,393), (B) US cancer survivors (n=12,990), (C) persons with
no prior cancer history (n=161,403).
approached but failed to meet the HP2010 goal of 70% of eligible
women having received a mammogram in the previous 2 years in
2010. The reported proportion was at 69.4% representing more
than 3.3 million women over the age of 40 years. There was an
average annual change of −4.3% and a prevalence of 61.8± 1.2%
representing more than 3.7 million women in 2010 for CBEs.
Cervical cancer screening
There was a 3.7% decrease in self-reported Pap test among women
18 years and older between 1999 and 2010. The HP2010 goal for
cervical cancer screening in women above 18 years was 90%. When
screening adherence was defined based on the recommendations
issued earlier in the decade, 84.7% of the population in 2010
reported adherence to Pap test guidelines. However, there was a
slight increase to 85.5% in the same population when adherence
included the change in recommendations in 2009.
Prostate cancer screening
In 1999, 64.6% of the eligible male population reported get-
ting a PSA test in the previous 12 months. There was an average
annual decline of −3.6% until 2010 with a reported prevalence of
46.0%representing an estimated 1.3 million men over 50 years.
TRENDS AMONG CANCER SURVIVORS
Overall, Cancer survivors (Figure 1B) demonstrated a compar-
atively higher adherence to recommended screening than the
persons with no cancer history.
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Colorectal cancer screening
There was a lower average annual increase in colorectal screen-
ing (3.3%; 18,554 persons) compared to the general population,
but baseline screening rates were on average approximately 10%
higher. Survivors were consistently above the HP2010 colorectal
screening goal of 50% throughout the entire decade.
Series of trend graphs illustrating adherence to cancers
amenable to routine screening, according to ACS guidelines. Data
source: NHIS 1997–2010.
Breast cancer screening
Among survivors, mammography declined between 2000 and
2003 (78.3± 2.6% to 74.9± 2.8%) and again between 2005 and
2008 (77.4± 2.8% to 74.2± 3.2%), but increased to 75.6% in
2010 (Table 2). Despite the decade long fluctuation in screen-
ing prevalence, cancer survivors surpassed the HP2010 goal for
mammography screening. An estimated 488,104 women reported
receiving a mammogram within the previous 2 years in 2010.
Reported CBEs declined among survivors from 77.8± 2.5% in
1999 to 68.0± 2.5% in 2010. The average annual decline of 3.2%
over the decade represented an estimated 403,084 eligible women
who reported not having a clinical breast examination in the rec-
ommended period. No CBE screening data were available for 2003
and 2008.
Cervical cancer screening
There was a small annual average decline of 1.5%, representing
an approximate 38,000 fewer women who reported receiving a
recommended pap test between 1999 and 2010. There were undu-
lations in the trend in adherence throughout the decade. This is
the only cancer for which survivors failed to meet the HP2010 goal
throughout the decade.
Prostate cancer screening
Compared to the general population, survivors received PSA test-
ing at a consistently 10–20% higher rate. Within this group the
trend across the years showed a decline from 76.5± 4.1% in 1999
to 64.3± 2.9% in 2010.
TRENDS AMONG PERSONS WITHOUT A HISTORY OF CANCER
Persons without a history of cancer demonstrated lower adherence
to recommended screening guidelines for most cancers amenable
to screening compared to cancer survivors (Figure 1C).
Colorectal cancer screening
The average annual increase in colorectal screening was 4.1% rep-
resenting an estimated 473,573 more persons screened each year.
Persons without a history of cancer surpassed the HP2010 goal for
colorectal screening in 2010 at 52.0%.
Breast cancer screening
Mammography trend was similar to the general population.
There was a decline between 2000 and 2005 (69.4± 1.3% to
68.1± 1.2%), followed by an increase to 68.5% in 2010. Reported
CBEs declined from 74.5± 0.8%in 1999 to 61.0± 0.4% in 2010,
an estimated decrease of 654,130 examinations during the recom-
mended period (Table 2).
Cervical cancer screening
Though there was a small annual average decline of 0.9%, a cumu-
lative 2.5 million fewer women reported receiving a recommended
pap test between 1999 and 2010. The population failed to meet the
HP2010 goal throughout the decade.
Prostate cancer screening
Among men without a history of cancer, the trend in PSA testing
declined from 63.4± 2.0% in 1999 to 42.5± 1.9% in 2010. This
represents more than 5.5 million men over 50 years old who did
not participate in PSA screening since 1999.
TRENDS AMONGWORKING SURVIVORS
Disparities in screening across occupational sectors were observed
over the decade among working cancer survivors (n= 7,528).
Farming sector estimates were not presented because of small
sample sizes. Table 3 shows that the annual cancer screening rates
among working cancer survivors significantly increased for only
four of 15 cancer screening/occupation subgroups over the period
1999–2010. The percent change is a summary measure of the dif-
ference in prevalence of adherent screening between 1999 and
2010. Table 5 illustrates the results of comparing the trend (slope)
in screening over the decade.
Colorectal cancer screening
Based on the average population, the increase among working sur-
vivors white-collar (5.1%), blue-collar (7.9%), and service work-
ers (3.4%) who received colorectal screening is representative of
an estimated 70,245; 33,117, and 8,830 Americans within each
sector, who reported following recommended guidelines. There
were significant differences in colorectal screening trends over the
decade between white-collar and blue-collar working survivors
(p= 0.016).
Breast cancer screening
There was an average annual 1.3% decline among white-collar
workers representing 16,233fewer women who reported not
receiving mammograms in between 1999 and 2010. There was
an even larger average annual decline (−3.3%) in the service sec-
tor, but an average increase of 2.5% among blue-collar workers.
There was a decline in CBEs between 1999 and 2010 across all
sectors with the largest average change occurring in the service
sector (−8.2%) and the smallest change within the blue-collar sec-
tor (−4.8%). There were no significant within group differences
in mammography trends among working survivors, however the
trend in CBE was significantly different between white-collar and
blue-collar working survivors (p= 0.005).
Cervical cancer screening
There was a decrease in adherence to Pap test recommendations
across all occupation sectors between 1999 and 2010; except for
service workers who demonstrated a 3.8% increase in adherence
in 2010 when compared to 2008. In 1999, survivors employed in
the white-collar sector met the 2010 goal at 92.9%. They main-
tained a greater than 90% of population screened until 2003, after
which the continued decline led to all workers falling below rec-
ommended screening levels. The adherent population within all
three sectors was between 8 and 20% below the HP2010 goal in
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Table 3 |Trends in Recommended screening among working cancer survivors (National health interview survey 1999–2010).
Survey year Average annual sample size Percent adherent to screening Average annual%
change
Regression
Observed N Population estimate 1999 2000 2003 2005 2008 2010 Slope±SEb P c
COLORECTAL SCREENINGa
White-collar 480 275,468 n/a 51.3 66.6 67.3 66.0 71.8 5.2 0.014±0.003 <0.001
Blue-collar 150 83,840 n/a 32.1 47.2 59.4 58.7 63.6 7.9 0.018±0.021 0.004
Service 94 50,454 n/a 48.9 62.0 54.8 57.4 62.3 3.4 0.011±0.006 0.075
MAMMOGRAMa
White-collar 388 208,109 84.1 81.2 78.8 81.7 80.5 77.4 −1.3 −0.003±0.002 0.230
Blue-collar 60 30,142 63.9 58.1 77.1 69.9 68.5 76.3 2.5 0.013±0.006 0.024
Service 268 36,162 88.4 84.0 82.5 64.5 59.3 72.1 −3.3 −0.005±0.006 0.461
CLINICAL BREAST EXAMa
White-collar 419 188,170 88.5 83.0 n/a 75.2 n/a 64.8 −7.9 −0.117±0.002 <0.001
Blue-collar 68 330,507 78.4 63.3 n/a 63.2 n/a 64.0 −4.8 −0.007±0.005 0.201
Service 76 35,832 87.3 71.3 n/a 58.3 n/a 62.6 −8.2 −0.003±0.006 0.662
PAPTESTa
White-collar 415 221,681 91.7 93.6 89.6 88.8 88.0 79.3 −4.7 −0.007±0.002 <0.001
Blue-collar 66 32,245 87.6 93.7 92.6 79.5 76.1 70.1 −4.6 −0.011±0.004 0.01
Service 84 44,096 89.2 96.9 89.4 88.6 80.2 84.0 −2.0 −0.006±0.004 0.18
PROSTATE SPECIFIC ANTIGENTESTa
White-collar 152 96,002 78.4 70.0 69.0 71.5 74.8 66.8 −2.3 −0.002±0.004 0.613
Blue-collar 78 46,138 69.8 52.5 81.0 61.3 62.3 59.7 −2.0 −0.006±0.008 0.437
Service 32 17,302 73.2 64.5 61.9 49.7 71.5 64.4 −1.8 0.009±0.007 0.247
aToo few observations in farming sector.
bStandard error of the mean.
cp-value.
2010. White-collar survivors showed a significant difference in the
trend in Pap tests over the decade when compared to working
survivors in blue-collar (p≤ 0.0001) and service <0.0001) occu-
pations. There were no significant differences in trends between
service and blue-collar working survivors (Table 5).
Prostate cancer screening
An estimated average 158,850 male working cancer survivors over
the age of 50 years reported having a PSA test within 1 year of
the NHIS interview. All occupational sectors were characterized
by a greater than 70% adherence to annual PSA testing guidelines
among working male survivors in this age group. Whereas there
was an average decline between 1999 and 2010 within all occu-
pations, there were fluctuations in trends across time. There were
no significant within group differences in PSA screening trends
among working survivors.
TRENDS AMONGWORKERS WITH NO HISTORY OF CANCER
Colorectal cancer screening
Based on the average population, there was an estimated increase
of 313,886 white-collar workers, 100,923 blue-collar workers and
64,371 service workers who reported having a colorectal screening
examination within the recommended time frame. The aver-
age yearly increase in screening showed little variation between
occupational groups (Table 4). Comparisons of trends in colorec-
tal screening between working persons without a cancer history
yielded no significant differences (Table 5).
Breast cancer screening
There was an average annual 0.6% decline among white-collar
workers representing 53,644 fewer women who reported not
receiving mammograms in 2010 when compared to their 1999
cohort. There was a larger average annual decline (−0.8%) in the
blue-collar sector, but an average increase of 0.4% among service
workers. There was a decline in CBEs between 1999 and 2010
across all sectors with the largest average change occurring in the
blue-collar sector (−7.8%) and the smallest change within the ser-
vice sector (−4.6%). The reported decline in proportion of CBEs
represented more than 95,000 and 63,000 eligible blue-collar and
service workers who failed to seek screening within the recom-
mended time frame each year throughout the decade. Between
occupations investigations of trends in breast cancer screening
among working persons without a cancer history showed no
significant differences.
Cervical cancer screening
There was a decrease in adherence to Pap test recommendations
across all occupation sectors. The decline was consistent within
the white-collar and blue-collar occupation sectors until 2008
after which there was an increase of approximately 1.0% in 2010.
The service sector workers demonstrated an earlier elevation in
adherence with a 3.0% increase between 2000 and 2008 and an
approximate 1.0% increase between 2008 and 2010. With the
annual average population estimated at more than 2.9 million,
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Table 4 |Trends in recommended screening among working persons with no cancer diagnosis (National health interview survey 1999–2010).
Survey year Average annual sample size Percent adherent to screening Average annual
% change
Regression
Observed N Population estimate 1999 2000 2003 2005 2008 2010 Slope±SEb P c
COLORECTAL SCREENINGa
White-collar 1,998 1,162,541 n/a 36.7 42.3 48.5 53.9 58.2 5.4 0.023±0.001 <0.0001
Blue-collar 652 366,995 n/a 24.8 34.1 37.7 44.0 46.8 5.5 0.022±0.002 <0.0001
Service 470 242,911 n/a 25.8 32.5 35.7 41.9 47.0 5.3 0.023±0.002 <0.0001
MAMMOGRAMa
White-collar 2,812 1,490,118 76.4 74.3 74.8 73.9 72.8 73.6 −0.6 0.003±0.001 0.669
Blue-collar 493 221,237 64.1 59.9 63.9 62.1 61.0 60.1 −0.8 −0.001±0.002 0.698
Service 567 275,723 60.4 66.6 57.8 60.7 64.5 62.4 0.4 0.005±0.002 0.009
CLINICAL BREAST EXAMa
White-collar 4,303 2,098,990 82.1 76.6 n/a 69.1 n/a 67.2 −5.0 −0.010±0.001 <0.001
Blue-collar 649 306,093 72.4 63.2 n/a 50.4 n/a 49.1 −7.8 −0.019±0.002 <0.001
Service 768 347,708 68.9 0.6 n/a 54.5 n/a 55.0 −4.6 −0.005±0.002 <0.001
PAPTESTa
White-collar 5,560 2,917,742 92.9 90.9 90.4 89.3 87.9 88.4 −1.8 −0.002±0.0004 <0.001
Blue-collar 1,025 457,033 88.0 83.7 83.3 78.2 80.4 81.5 −2.9 −0.003±0.001 0.005
Service 1,182 598,622 87.2 83.4 82.5 81.1 84.1 85.0 −1.4 0.003±0.001 0.682
PROSTATE SPECIFIC ANTIGENTESTa
White-collar 639 394,574 60.7 61.4 56.0 49.0 51.6 49.8 −2.2 −0.005±0.002 0.003
Blue-collar 308 186,188 52.9 48.5 55.3 37.3 41.7 36.5 −3.3 −0.004±0.003 0.012
Service 177 95,329 55.8 43.3 49.8 35.4 39.3 33.9 −4.4 −0.014±0.003 <0.001
aToo few observations in farming sector.
bStandard error of the mean.
cp-value.
white-collar workers met the HP2010 goal between 1999 and 2003.
No other sector met this goal throughout the decade. There were
no significant differences in trends in cervical cancer screening
between occupation groups among working women without a
cancer history.
Prostate cancer screening
Since 1999, more than 552,000 working men over the age of
50 years refrained from having an annual PSA test. PSA screening
was much lower among this population when compared to work-
ing survivors. There was an average decline between 1999 and 2010
within all occupations, with the largest observed decline among the
service sector (−4.4%). This was twice the rate of decline among
white-collar workers and a third higher than blue-collar workers.
In 2010 an average 40.1% of this subpopulation reported having
a PSA test in the past 12 months. They represented 270,437 of
working men over 50 years of age without a cancer history. There
were no significant differences in PSA screening trends between
occupation groups among working persons without a history of
cancer.
DISCUSSION
Although cancer-related mortality has declined in part due to
early detection, there has been continued debate regarding the
adequacy of screening and the over-diagnosis of indolent can-
cers (Mandelblatt and Cronin, 2011). Our results indicate that
there has been a general decline in adherence to recommended
screening throughout the decade, and that the general US popula-
tion failed to meet the HP2010 goal for all targeted screening exams
except colorectal screening. Cancer survivors, a population with an
increased risk of developing recurrences or new primary tumors,
met the goals for all common screening exams except cervical
cancer. However this group also illustrated a downward trend for
most screenings in the last 3 years of the study period. This declin-
ing trend foreshadows a future negative impact on mortality from
cancers of the breast, and cervix as well as increased morbidity
associated with a later diagnosis of prostate cancer. Disagreements
among the USPSTF, the ACS and other recommending bodies over
cancer screening guidelines may have contributed to the decline in
screening throughout the decade (Gotzsche, 2005; Kaplan, 2009;
Hendrick and Helvie, 2011; Takahashi et al., 2011). A decline in
worker insurance rates over the decade under study (Cunningham
et al., 2008; McCollister et al., 2010) could also be a contributing
factor.
BREAST CANCER TRENDS REFLECT UNCERTAINTY IN SCREENING
Whereas the average decline in mammography screening was low,
it still translated into over 31,000 fewer women reported being
screened in the previous 2 years in 2005 as compared to 2003. The
general population failed to meet the HP2010 goal of 70% for
most of the decade, except in 2010 when it was met. Survivors
exceeded the mammography goal throughout the entire decade
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Table 5 | Comparison of trend (slopes) in adherence to cancer screening over the decade (National health interview survey 1999–2010).
Colorectal screening Mammogram Clinical breast exam Pap test PSA
Esta±SEb Est.±SE Est.±SEb Est.±SEb Est.±SEb
GENERAL POPULATION
Survivor vs. no
cancer history
0.019±0.016
pc=0.242
0.028±0.024
p=0.252
0.034±0.025
p=0.167
0.030±0.017
p=0.069
0.059±0.019
p=0.002
WORKING CANCER SURVIVORS
WCd vs. BCe 0.008±0.003
p=0.016
0.002±0.003
p=0.374
0.007±0.003
p=0.005
0.010±0.002
p≤0.0001
0.006±0.005
p=0.217
WC vs. service 0.006±0.006
p=0.339
−0.008±0.006
p=0.200
−0.002±0.005
p=0.748
0.022±0.005
p≤0.0001
0.005±0.008
p=0.554
BC vs. service 0.077±0.021
p=0.726
−0.037±0.031
p=0.242
−0.032±0.032
p=0.320
−0.028±0.022
p=0.191
−0.042±0.024
p=0.073
WORKING PERSONSWITHOUTA HISTORY OF CANCER
WC vs. BC 0.002±0.021
p=0.908
0.022±0.032
p=0.486
−0.001±0.033
p=0.968
0.038±0.022
p=0.079
0.016±0.023
p=0.482
WC vs. service 0.004±0.009
p=0.633
0.004±0.010
p=0.703
−0.015±0.009
p=0.103
0.013±0.007
p=0.067
−0.017±0.011
p=0.131
BC vs. service 0.002±0.020
p=0.923
−0.018±0.031
p=0.560
−0.013±0.032
p=0.682
−0.025±0.022
p=0.246
−0.033±0.023
p=0.152
aEstimate.
bStandard error.
cp-value.
dWhite-collar.
eBlue-collar.
but showed a larger decline between 2000 and 2005 than the gen-
eral population. The difference in trend between these groups was
significant. Others reported that the greatest decline in mammo-
grams had been among women between 50 and 59 years of age as
well as among highly educated women in white-collar jobs (Breen
et al., 2007). Breast cancer screening prevents over 2.0% of cancer
deaths annually (Altekruse et al., 2010), thus early detection is of
key importance to the groups at increased risk such as breast cancer
survivors (Brewster et al., 2008) and women over 50 years of age
(Mandelblatt et al., 2009). We did not detect any significant occu-
pational differences in the rate of change in breast cancer screening
within groups according to cancer history.
INCREASING HPV VACCINATION MAY CONTRIBUTE TO DECREASING
PAP TESTS
We observed a higher cervical screening rate when we examined
women 21 years and older compared to women 18 years and older.
On average, approximately 131,000 fewer women had a pap test
each year, with a significant decline between 2003 and 2005. There
was a declining trend among cancer survivors, but the most notice-
able decrease occurred after 2008. Though not explored in our
analyses due to data limitations, we speculate that in addition
to changing guidelines this decline may be associated with the
extension of the Human Papillomavirus (HPV) vaccine to young
women up to 26 years. There has been a 10.2% increase in HPV
vaccination among women 19–26 years since its introduction to
this age group in 2008 (Williams, 2012). However, as the available
vaccines protect women from only two to four of the many cancer-
causing HPV infections, this trend of higher vaccinations at the
price of lower screening may be more detrimental than the previ-
ous unavailability of a vaccine but higher screening rates (Harper,
2009). Unexpectedly, cancer survivors had a lower screening rate
than their peers without a prior diagnosis for several periods over
the decade but there was no significant difference in trend between
the two groups, overall. This important decline underlines the
urgent need of implementing information campaigns emphasiz-
ing the need to continue screening despite the availability of an
effective but limited vaccine.
PSA SCREENING DECLINED AS ITS EFFECTIVENESS WAS QUESTIONED
In 1999, 1.1 million men participated in PSA screening within a
12-month period. They represented 64.6% of males over 50 years
of age. This proportion decreased throughout the decade but in
2010 NHIS data reflected more than1.3 million men who had a
PSA test within a 12-month period. Though population estimates
pointed to an increase in the number screened, this proportion
was representative of 46.0% of males over 50 years, an almost 20%
decline since 1999. Based on recent reports on the deficiencies of
PSA as a diagnostic tool (Thompson et al., 2006; Simmons et al.,
2011), the consensus of all recommending bodies is that the risk
of routine PSA screening (e.g., unnecessary tests and/or surgeries
for indolent cancers) far outweighs the benefits. This and other
reports of the greater likelihood of outliving the disease among
most men may have influenced the observed decline. Though not
as large as among the general population, there was an observed
reduction in the number of male cancer survivors who reported
having an annual PSA screening test. The trends for these two
groups were significantly different.
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HP2010 GOALS MET FOR COLORECTAL SCREENING
Based on a consistent increase since 2003, the US population
achieved and maintained the HP2010 goal of 50% adherence to
ACS guidelines for colorectal screening from 2008 through 2010.
Cancer survivors, who already started out at 54.7% at the begin-
ning of the decade, experienced a smaller increase between 2008
and 2010. Routine screening can reduce the number of people
who die from colorectal cancer by at least 60% (Center for Disease
Control and Prevention (CDC), 2012), and though increasing, the
proportion screened is still disproportionate to the proven benefits
of early detection.
LEVEL OF ADHERENCE BY CANCER HISTORY
There are a myriad of determinants affecting a person’s deci-
sion to seek cancer screening such as perceived vulnerability to
cancer (Calvocoressi et al., 2004; Rutten et al., 2005) or level of
acceptability of screening practices (Breen et al., 2011). Whereas
screening rates for some cancers are still below recommended lev-
els, cancer survivors consistently exceeded population rates by over
an average 10% throughout the decade. Survivors exceeded the
HP2010 goal in spite of a decline in rates since 2000. A small
but significant downward trend was observed in the proportion
of women who reported having had a Pap test within the pre-
vious 3 years, regardless of cancer history. However, rates were
consistently higher among survivors. It is assumed that survivors
are more likely to adhere to recommended cancer screening due
to their experience with the disease, awareness of their increased
risk for second cancers, and first-hand knowledge of the bene-
fits of screening. However, the experience of continuing working
or returning to work varies for survivors according to occupa-
tion, e.g., access to health insurance coverage, which may influence
adherence to screening. As such, employment disparities among
survivors must be addressed (Messner and Vera, 2011).
SCREENING DIFFERS AMONGWORKING SURVIVORS
In general, the more highly educated, white-collar cancer sur-
vivor employed in an occupation which provides comprehensive
private health insurance is more likely to be among the early
adopters of screening practices (Fleming et al., 2007). We found
that white-collar workers had significantly higher screening rates
of mammography, CBEs, and pap tests compared to blue-collar
workers, but were comparable to service workers. However, since
2005 breast cancer screening among white-collar workers declined
while increasing among blue-collar and service workers. Previous
occupational health studies identified blue-collar workers as the
working population most likely to report poor health, functional
limitations, lack of information on preventive health behaviors
and reduced healthcare access and utilization (Quintiliani et al.,
2007; Clarke et al., 2011). Disparate health behaviors among this
worker group are often magnified by chronic diseases such as
cancer. Historically, blue-collar workers have reported taking fewer
days-off and sick days than their white-collar peers regardless of
reported health status (Lee et al., 2006).
White-collar survivors, similar to their colleagues without a
cancer diagnosis, appeared to be more receptive to cancer screen-
ing than survivors employed in the service and blue-collar sectors.
Service workers do not fare much worse than white-collar work-
ers with regards to many known health benefits (Schmitt, 2009),
and did not fall far behind in adherence to screening, especially
for Pap tests and PSA screening. Public debate over the value of
cancer screening will continue as new scientific discoveries lead to
changing guidelines. This may or may not translate into reduced
adherence to screening. In fact, our results showed that the US
achieved the HP2010 goal of 50% adherence to recommended
colorectal screening and 70% adherence to mammography screen-
ing despite the change in recommendations along the decade.
On the other hand, women 18 years and older experienced a
decline in pap tests over the past few years and the HP2010 goal
remained unmet, and mammography screening fluctuated over
the decade. Whether the new mammography and Pap test guide-
lines will influence future screening decisions is uncertain. It is
also unknown if the USPSTF’s reiteration of the ineffectiveness of
PSA as a population-wide cancer screening tool will lead to fur-
ther reductions in testing. Physicians continue to recommend PSA
screening for high risk patients but existing barriers such as those
identified by Pollack et al. (2012), may be further complicated by
reinforcing the message of more harm than good with regards to
this screening exam. Despite demonstrating higher screening rates
than the general population, it is evident that cancer survivors had
a slight decline in screening rates and are in need of continued
medical advice post-treatment and diagnosis. Further, screening
rates among survivors differ according to occupational sectors.
Our findings should be interpreted in the context of the study’s
limitations. First, the data for our main outcome variables, screen-
ing procedures, are self-reported. However, our primary goal was
to analyze trends over time, and the expected rate of over-reporting
of a “desirable behavior” may be assumed to not vary significantly
across survey years. As a result, the bias introduced is unlikely
to impact our main findings significantly and, thus, we assume
that our results regarding percent change in screening behaviors
reflect actual trends. Second, the sample size of cancer survivors
employed in the farming sector, was too small for analysis, thus,
our comparisons by occupational sector are limited to white-collar,
blue-collar, and service workers.
Finally, due to data limitations, we do not know what type of
Pap test (liquid-based or glass smear) was performed on women
screened for cervical cancer. Because the time between screenings
varies from 2 to 3 years depending on the test used, we may have
under- or over-estimated those rates. Further, we had no data on
the age at first coitus which may determine the recommended time
of the first Pap test (at 18 years of age or 3 years after first sexual
activity).
Our research findings are strengthened by the use of the
NHIS, a nationally representative sample of the entire US pop-
ulation, which yielded a pooled sample of more than 7,500
working cancer survivors available for analysis. Consequently,
the data reflect similar screening rates in the general popula-
tion presented by the NCI in earlier years for some of the can-
cers assessed in this research (National Cancer Institute (NCI),
2010). The use of a trend analysis to investigate changes provides
a systematic review of historical patterns in screening behavior
while permitting the assessment of occupational differences within
each year.
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In summary, population-based information about cancer sur-
vivors is useful for researchers, public health practitioners, and
program implementers responsible for the development and
assessment of interventions aimed at improving the health and
quality of life in this growing segment of the US popula-
tion. Examining this information by occupational group is the
next logical step in the effort to overcome any existing struc-
tural inequalities existing within working cancer survivors and
promote policies aimed at meeting the needs of all employed
groups (Dani and De Haan, 2008). However, this is a dif-
ficult task as most laws and public policies are written in
a general format. Unfortunately, a “one-size-fits-all” approach
will not lead to a decrease in occupation-related disparities
in cancer screening. Hence, we hope that further research in
this field will also examine the combined effect of other social
determinants (psychosocial, logistic, and financial) that may
influence screening decisions. A comprehensive approach may
better inform the design of targeted workplace interventions
to increase screening among the general population, with a
special focus on cancer survivors, and tailored to the chal-
lenges and opportunities afforded within each occupational
sector.
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